Abstract A033: Targeting ROR2 with an antibody-drug conjugate to overcome MYOD1L122R-driven therapy resistance in rhabdomyosarcoma
Year: 2025
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414502495
